Furthermore, it should be emphasized that the study applies to a specific patient population, ie those suffering from systolic decompensation, that represent the minority of patients subject to readmissions due to heart failure. Most re-admissions due to decompensation take place in patients with preserved ejection fraction (pEF) and are often related to comorbidities. (Roger VL. Epidemiology of heart failure. Circ Res. 2013; 113:646-59. doi:10.1161/CIRCRESAHA.113.300268.) Since RCTs performed up to now have not been able to identify treatments with a prognostic impact in patients with heart failure and pEF, in this specific group therapeutic uncertainty is greater than in patients with heart failure and reduced EF; since there are only a few strong recommendations in therapeutic guidelines about heart failure with pEF, the prescriptive variability is expected to be greater in this field, as greater is the probability of errors and/or changes in the management of medicines through the transition from hospital to primary care. Given that the presence of comorbidities further complicates the management of medical therapy, it would be interesting to know the distribution of comorbidities in the patients included in this study.
With regard to bridges and props, the added-value of the titration clinics managed by pharmacists can be reinforced by the recent demonstration of the better arterial pressure control in hypertensive black people through pharmacological intervention led by pharmacists in barber shops versus the usual care. (N Engl J Med 2018; 378:1291 -1301 . DOI: 10.1056/NEJMoa1717250).
In short, this study analyzes a delicate aspect of medical practice, namely the management of medical therapy at discharge from hospital. This is a complex and poly-parametric field, that has been correctly analyzed by the authors from multiple perspectives (hospital doctors, GPs, patients, pharmacists) and with an appropriate methodology. The study sheds light on some virtuous aspects of drug management at hospital discharge. In this sense it can be a basis (and/or an integration) for methodologically sound clinical studies (eg cluster RCTs). However, just because it is a case study, I consider mandatory to replace the term "demonstrates" with the term "suggests" (third line of the discussion). In short, I would accept the paper with minor revision.
I have a few suggestions for improvement, which are more around the definition and use of Safety-II concepts rather than specifically on the topic of medicines management.
(1) terminology: it would be helpful to clarify key terms and concepts. For example p3/l42 "errors" -are these human errors, medication errors, or what kind of errors? p4/l3 "specific risks" and p15/l31 "minimise the risk of error" -again, how is risk defined? What does minimising the risk of error mean? Reducing the likelihood of its occurrence?
(2) Safety-II: how do the concepts of error and risk sit with Safety-II? Error hasn't been defined in the paper, but is usually something like deviation from a procedure / standard, or a negative outcome. Risk could be defined as the combination of likelihood of occurrence of a hazard and the severity of the consequences. These are all negative. Safety-II does not normally operate with such concepts, so it would be helpful to include the authors' interpretation. The intrinsic ability of a system to adjust its functioning prior to, during, or following changes and disturbances, so that it can sustain required operations under both expected and unexpected conditions." This is the given on the website of the resilient healthcare network is, "A system is resilient if it can adjust its functioning prior to, during, or following events (changes, disturbances, and opportunities), and thereby sustain required operations under both expected and unexpected conditions." Page 4 line 18 -Resilience is therefore more than compensating for weaknesses but also responding to opportunities. I think you have studied this -for example by considering opportunities for patients to contribute to creating safety. Page 4 line 21 typo "where resilience in the exists" Page 5 line 6 -"A quota sample of between 16-24 admitted patients was constructed to allow for attrition, aiming for 16 complete datasets." For me this could be clearer. It could also state this is the composite total between the four sites. Page 5 line 38 -how were healthcare staff recruitedconvenience sample/ purposive?? Page 6 line 6 -document analysis on page 4 line 30 stated that using case note review for document analysis, This is not mentioned here in the analysis section. Page 6 line 10 -states "Examples of system resilience at care transitions and risks in the system were extracted using a framework that mapped them according to the point in the transition to which they related and to the resilience element (or lack of) they evidenced." Are these examples of resilience potential recorded in official documents? Or does this refer to patient case note review and examples of resilience found? I don't think you can say a document (protocol/guidance etc) shows system is resilientmaybe it indicates that there is potential to be resilient. Page 6 line 24. It states that data analysis was iterative then that "The research team met several times to discuss the data synthesis and analysis method and the emerging themes." I think this should be more specific -did the research team meet between data collections to discuss the data synthesis and analysis method and the emerging themes? Page 6 line 31 -The emerging analysis was thematic. Could this be clarified -my understanding of framework analysis is that thematic analysis is conducted as part of the process -so themes emerge not the analysis? Page 8 line 15 second time heading "Results" has appeared Page 8 line 30 -a 'gap' defined as a discontinuity of key process. The following is given as an example of a gap:
"For the latter, we identified no standardised processes for informing patients about their medicines and, while hospital policies stipulated that patients should be informed, and gave details of the types of information patients should have, there was no guidance on optimal methods for informing patients about their medicines or training in doing so." The 'gap' is that the patients did not receive the correct information. The lack of guidance is a contributory factor (probably one of many) in why this happens. The lack of guidance and training is certainly a gap in the 'system-as-found' but is it a discontinuity of a key process or does it just not exist? It may be that this actually is a trap as it relates to the way the system is designed -there is no guidance or training. On page 9 line 34 -you infer that a similar problem in primary care is a trap and not a gap.
Page 10 line 40 -GP staff says prioritise based on risk readmission -is this formal and training given? If so, then agree it is a bridge, if not it is a prop. Props -informal resilient behaviour -but as soon as this becomes the formal system then do they become bridges?
TABLES
In tables -few abbreviations need expanded HCA and MCCA HFSN TTO Table 7 row 8 -What are ambulatory services? Furthermore, it should be emphasized that the study applies to a specific patient population, ie those suffering from systolic decompensation, that represent the minority of patients subject to readmissions due to heart failure. Most re-admissions due to decompensation take place in patients with preserved ejection fraction (pEF) and are often related to comorbidities.
(Roger VL. Epidemiology of heart failure. Circ Res. 2013; 113:646-59. doi:10.1161/CIRCRESAHA.113.300268.) Since RCTs performed up to now have not been able to identify treatments with a prognostic impact in patients with heart failure and pEF, in this specific group therapeutic uncertainty is greater than in patients with heart failure and reduced EF; since there are only a few strong recommendations in therapeutic guidelines about heart failure with pEF, the prescriptive variability is expected to be greater in this field, as greater is the probability of errors and/or changes in the management of medicines through the transition from hospital to primary care. Given that the presence of comorbidities further complicates the management of medical therapy, it would be interesting to know the distribution of comorbidities in the patients included in this study. Pager 3 line 52 There is a more up to date definition of resilience In the fourth book (Resilience Engineering in Practice, 2010) the definition is given as, "The intrinsic ability of a system to adjust its functioning prior to, during, or following changes and disturbances, so that it can sustain required operations under both expected and unexpected conditions." This is the given on the website of the resilient healthcare network is, "A system is resilient if it can adjust its functioning prior to, during, or following events (changes, disturbances, and opportunities), and thereby sustain required operations under both expected and unexpected conditions."
Definition updated and references added
This in turn promotes a more dynamic attitude to performance through resilience which we define here as the ability for a system and the individuals therein to adjust prior to, during of following bounce back after any changes disruption or failure or disturbances or in the face of ongoing, sustained pressure
Page 4 line 18 -Resilience is therefore more than compensating for weaknesses but also responding to opportunities. I think you have studied this -for example by considering opportunities for patients to contribute to creating safety.
More specifically, the study was designed to understand how the system compensates for weaknesses and maximises opportunities in order to deliver safe yet optimal treatment.
Page 4 line 21 typo "where resilience in the exists" We have corrected this typo Page 5 line 6 -"A quota sample of between 16-24 admitted patients was constructed to allow for attrition, aiming for 16 complete datasets." For me this could be clearer. It could also state this is the composite total between the four sites.
A quota sample of 4-6 patients in each site was constructed, aiming for at least 16 complete datasets in total in the four areas
Page 5 line 38 -how were healthcare staff recruited -convenience sample/ purposive??
Have reworded this sentence A range of healthcare professionals involved in medicines management were selected following ward observations Page 6 line 6 -document analysis on page 4 line 30 stated that using case note review case notes and communications such as for document analysis, This is not mentioned here in the analysis section. discharge letters. We aimed to include a range of healthcare professionals involved in medicines management.
Page 6 line 10 -states "Examples of system resilience at care transitions and risks in the system were extracted using a framework that mapped them according to the point in the transition to which they related and to the resilience element (or lack of) they evidenced." Are these examples of resilience potential recorded in official documents? Or does this refer to patient case note review and examples of resilience found? I don't think you can say a document (protocol/guidance etc) shows system is resilient -maybe it indicates that there is potential to be resilient.
They were identified as potential sources of resilience Examples of potential system resilience at care transitions and risks in the system were identified and Page 6 line 24. It states that data analysis was iterative then that "The research team met several times to discuss the data synthesis and analysis method and the emerging themes." I think this should be more specific -did the research team meet between data collections to discuss the data synthesis and analysis method and the emerging themes?
We have clarified this The research team met several times both during and following data collection to discuss the data synthesis and analysis method and the emerging themes
Page 6 line 31 -The emerging analysis was thematic. Could this be clarified -my understanding of framework analysis is that thematic analysis is conducted as part of the process -so themes emerge not the analysis?
We have deleted this confusing line Page 8 line 15 second time heading "Results" has appeared Thank you we have deleted this
Page 8 line 30 -a 'gap' defined as a discontinuity of key process. The following is given as an example of a gap: "For the latter, we identified no standardised processes for informing patients about their medicines and, while hospital policies stipulated that patients should be informed, and gave details of the types of information patients should have, there was no guidance on optimal methods for informing patients about their medicines or training in doing so." The 'gap' is that the patients did not receive the correct information. The lack of guidance is a contributory factor (probably one of many) in why this happens. The lack of guidance and training is certainly a gap in the 'system-as-found' but is it a discontinuity of a key process or does it just not exist? It may be that this actually is a trap as it relates to the way the system is Thank you for pointing out this inconsistency.
For the latter, we identified no standardised processes for informing patients about their medicines and, while hospital policies stipulated that patients should be informed, and gave details of the types of information patients should have, there was no guidance on optimal methods for informing patients about their medicines or training, so patients' experiences of receiving medicines were inconsistent and designed -there is no guidance or training. On page 9 line 34 -you infer that a similar problem in primary care is a trap and not a gap.
information was deficient for some.
TABLES
In tables -few abbreviations need expanded HCA and MCCA HFSN TTO Table 7 
GENERAL COMMENTS
The authors have addressed previous suggestions, and I believe the manuscript has improved.
The paper makes a useful contribution towards highlighting the importance of studying everyday clinical work in order to better understand how healthcare organisations provide good quality care, and how they can improve further. A strength of the study is the large sample size (for a qualitative study), and the inclusion of a significant number of patient interviews.
